Gilead Sciences Announces Senior Management Promotion.FOSTER CITY, Calif. -- Gilead Sciences Gilead Sciences NASDAQ: GILD is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. , Inc. (Nasdaq:GILD) announced today the promotion of Jim Meyers to Senior Vice President, Commercial Operations, North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . Mr. Meyers is responsible for the company's commercial organization in North America, including U.S. and Canadian sales, marketing and commercial operations, reporting to Kevin Young Kevin Young may mean any of several people:
Mr. Meyers joined Gilead in 1996 as a regional sales director and relocated to the company's headquarters in 1997 to head the HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. marketing team. In 2001 he was named Senior Director of U.S. Sales, overseeing the expansion of the company's field sales organization in advance of the launch of Gilead's first product for the treatment of HIV. He was promoted to Vice President in 2002, and appointed to the position of Vice President of the U.S. Commercial organization in 2004. Prior to joining Gilead, Mr. Meyers held positions of increasing responsibility in sales, training, marketing and management with Zeneca Pharmaceuticals and Astra USA. He is a graduate of Boston College Boston College, main campus at Chestnut Hill, Mass.; coeducational; Jesuit; est. and opened 1863. Actually a university, the school's Chestnut Hill campus comprises colleges of arts and sciences and business administration, the graduate school, and schools of nursing , with a Bachelor's degree in economics. "Over the last ten years, Jim has contributed significantly to the growth and success of Gilead's commercial organization," said Mr. Young. "As we extend our commercial presence and expand into new therapeutic areas, Jim's leadership and depth of expertise will ensure we continue to meet our aggressive goals and deliver new medications to those patients most in need." About Gilead Sciences Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California
For more information on Gilead, please call the Gilead Public Affairs Those public information, command information, and community relations activities directed toward both the external and internal publics with interest in the Department of Defense. Also called PA. See also command information; community relations; public information. Department at 1-800-GILEAD-5 (1-800-445-3235) or visit www.gilead.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion